Joy Ventures

Joy Ventures, which rebranded to Corundum Neuroscience in November 2023, is a venture builder and fund that invests in and supports early-stage companies with a focus on neuroscience. The firm's 'lab-to-life' model supports the entire innovation journey from research to commercialization, aiming to develop solutions for health and disease areas like anxiety, depression, PTSD, chronic pain, sleep, and neurodegenerative disorders. It operates under its parent company, Corundum Innovation, a Japanese-based investment firm.